Literature DB >> 28952830

Time-Series Analysis of the Impact of Prescription Drug Monitoring Programs on Heroin Treatment Admissions.

Douglas Keith Branham1.   

Abstract

BACKGROUND: Prescription drug abuse has become a major issue in the United States in recent years. Prescription drug monitoring programs (PDMPs) are designed to help health care providers to prevent such abuses. There may be unintended effects of these programs. Specifically, PDMPs may move prescription opioid users to begin use of heroin.
OBJECTIVES: This article aims to evaluate the impact of PDMPs on heroin abuse across several different states through use of treatment admissions records obtained from the Treatment Episode Data Set.
METHODS: Operational dates and other characteristics of state PDMPs were obtained from the Prescription Drug Monitoring Program Training and Technical Assistance Center. Data for the dependent variable were collected from the Treatment Episodes Data Set from 1992 to 2012. Interrupted time-series analyses using autoregressive integrated moving average modeling were used to estimate the effect of presence of an operational PDMP on the number of admissions reporting heroin as their primary drug being used.
RESULTS: The relationship between heroin admissions and prescription opioid admissions was significant for the average data (β = 0.41, p = 0.0017) and the 5-year data (β = 0.5, p = 0.036), both showing positive associations between heroin and prescription drug admissions in states in the post PDMP implementation period. Conclusions/Importance: The study found a positive relationship that between heroin and prescription opioid admissions post PDMP implementation. Future research should attempt to identify what this relationship means and how this information can be used to improve opioid policy.

Entities:  

Keywords:  Heroin; prescription drug monitoring programs; prescription drugs; substance abuse treatment

Mesh:

Year:  2017        PMID: 28952830     DOI: 10.1080/10826084.2017.1363232

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  7 in total

1.  Systematic Literature Review of Prescription Drug Monitoring Programs.

Authors:  Aditya Ponnapalli; Adela Grando; Anita Murcko; Pete Wertheim
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

2.  Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US-Mexico Border.

Authors:  David Goodman-Meza; Maria Elena Medina-Mora; Carlos Magis-Rodríguez; Raphael J Landovitz; Steve Shoptaw; Dan Werb
Journal:  Am J Public Health       Date:  2018-11-29       Impact factor: 9.308

Review 3.  The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.

Authors:  Amanda I Mauri; Tarlise N Townsend; Rebecca L Haffajee
Journal:  Milbank Q       Date:  2019-12-04       Impact factor: 4.911

4.  A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018.

Authors:  Bahareh Ansari; Katherine M Tote; Eli S Rosenberg; Erika G Martin
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

5.  Transitioning from pharmaceutical opioids: A discrete-time survival analysis of heroin initiation in suburban/exurban communities.

Authors:  T L Gaines; K D Wagner; M L Mittal; J M Bowles; E Copulsky; M Faul; R W Harding; P J Davidson
Journal:  Drug Alcohol Depend       Date:  2020-05-28       Impact factor: 4.492

6.  Trends in Opioid Prescribing Following Pennsylvania Statewide Implementation of a Prescription Drug Monitoring Program.

Authors:  Chaim Miller; Asif M Ilyas
Journal:  Cureus       Date:  2022-08-11

7.  The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.

Authors:  Emily Rhodes; Maria Wilson; Alysia Robinson; Jill A Hayden; Mark Asbridge
Journal:  BMC Health Serv Res       Date:  2019-11-01       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.